Maha Katabi

Dr. Katabi joined Sectoral in 2008 as investment manager and in 2012 was promoted Partner, Private Equity. Prior to joining Sectoral, she was vice-president with Ventures West since 2004, a private venture capital firm with over $700 million under management based in Canada. In this capacity, she managed biotech investments across Canada and the United States, and served as a director of MacroGenics, NeurAxon, and Resonant Medical. Previously, she was an associate at T2C2 Capital, since 1999, an early stage fund investing in the life sciences space, and led several investments in start-ups and university spin-offs. She joined Chronogen Inc., one of the fund’s portfolio companies to serve as Vice President of business development in 2002. She holds a Ph.D. in Pharmacology (1999) and a B.Sc. in Biology (1994) from McGill University. She obtained her CFA charter in 2011.